Pulmonx Corporation (LUNG) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Pulmonx (LUNG) Q1 2026 Earnings Transcript
Pulmonx Corporation Q1 2026 Earnings Call Summary
Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
Pulmonx Corporation (LUNG) Q1 2026 Earnings Call Transcript
Pulmonx Q1 Earnings Call Highlights
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
Pulmonx Corp (NASDAQ:LUNG) Q1 2026 Revenue Miss and Falling Sales Drag Down Sentiment
Pulmonx Reports First Quarter 2026 Financial Results
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.920M Est
Pulmonx Q1 EPS $(0.33) Beats $(0.34) Estimate, Sales $20.586M Beat $20.432M Estimate
Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference
How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance
How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions
Pulmonx Corporation Q4 2025 Earnings Call Summary
Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ...
Pulmonx Q4 Earnings Call Highlights
Pulmonx (LUNG) Q4 2025 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.